Since Misoprostol Vaginal Insert (MVI - Misodel ®) was approved for labor induction in Europe in 2013, to date, no study has been published comparing MVI to Misoprostol vaginal tablets (MVT). The aim of this study, performed as part of a quality improvement project, was to compare the efficacy and safety of 200 μg MVI versus 25 μg MVT for labor induction in nulliparous women.
This retrospective cohort study included 171 nulliparous singleton term deliveries induced with MVI (n = 85) versus MVT (n = 86) at Oslo University Hospital Rikshospitalet, Norway, from November 2014 to December 2015. Primary outcomes were time from drug administration to delivery in hours and minutes and the rate of cesarean section (CS). Results were adjusted for Bishop Score and pre-induction with balloon catheter.
Median time from drug administration to delivery was shorter in the MVI group compared to the MVT group (15 h 43 min versus 19 h 37 min, p = 0.011). Adjusted for confounding factors, mean difference was 6 h 3 min (p = 0.002). The risk of CS was 67% lower in the MVI group compared to the MVT group (11.8% versus 23.3%, OR = 0.33; adjusted 95% CI 0.13–0.81). Adverse neonatal outcomes did not differ between the groups.
In a setting of routine obstetric care, MVI seems to be a more efficient labor induction agent than MVT, and with a lower CS rate and no increase in adverse infant outcomes.
European perinatal health report: Health and Care of Pregnant Women and Babies in Europe in 2010. Euro-Peristat. http://www.europeristat.com/reports/european-perinatal-health-report-2010.html. Accessed 03 Sept 2016.
Hofmeyr GJ, Gülmezoglu AM, Pileggi C. Vaginal misoprostol for cervical ripening and induction of labour. Cochrane Database Syst Rev. 2010;10
Misodel Summary of Product Characteristics. https://www.ferring.com/en/media/press-releases/2013/misodel-17oct13/. Accessed 01 Oct 2016.
Heads of Medicines Agencies. Misoprostol gynaecological indication PSUR SAR. 2015. http://www.hma.eu/search.html?id=6&q=misodel&L=0. Accessed 28 Sept 2016.
Dobert M, Brandstetter A, Henrich W, Rawnaq T, Hasselbeck H, Dobert TF, Hinkson L, Schwaerzler P. The misoprostol vaginal insert compared with oral misoprostol for labor induction in term pregnancies: a pair-matched case-control study. J of. Perinat Med. 2017;
Gornisiewicz T, Jaworowski A, Zembala-Szczerba M, Babczyk D, Huras H. Analysis of intravaginal misoprostol 0.2 mg versus intracervical dinoprostone 0.5 mg doses for labor induction at term pregnancies. Ginekologia pol. 2017;88(6):320–4. CrossRef
Robson M, Murphy M, Byrne F. Quality assurance: the 10-group classification system (Robson classification), induction of labor, and cesarean delivery. Int J Gynaecol Obstet. 2015;131:23–7. CrossRef
Crane JMG, Delaney T, Butt KD, Bennett KA, Hutchens D, Young DC. Predictors of successful labor induction with oral or vaginal misoprostol. J Matern Fetal Med. 2004;15(5):319–23. CrossRef
van Gemund N, Scherjon S, LeCessie S, van Leeuwen JHS, van Roosmalen J, Kanhai HHH. A Randomised trial comparing low dose vaginal misoprostol and dinoprostone for labour induction. BJOG 2004; 111(1):42–49.
Norwegian Institute of Public Health. Medical Birth Registry of Norway. http://statistikk.fhi.no/mfr/. Accessed 18 Oct 2016.
European Medicines Agency. List of nationally authorised medical products Active substance: Misoprostol (gynaecological indication - labour induction). http://www.ema.europa.eu/docs/en_GB/document_library/Periodic_safety_update_single_assessment/2017/03/WC500223582.pdf. Accessed 02 Jan 2018.
NHS Digital. NHS Maternity Statistics - England, 2013–14. https://digital.nhs.uk/catalogue/PUB16725. Accessed 19 Oct 2016.
Kim LH, Cheng YW, Delaney S, Jelin AC, Caughey ABI. Preeclampsia associated with an increased risk of cesarean delivery if labor is induced? J Matern Fetal Med. 2010;23(5):383–8. CrossRef
- A comparison of misoprostol vaginal insert and misoprostol vaginal tablets for induction of labor in nulliparous women: a retrospective cohort study
Kjersti Engen Marsdal
Ingvil Krarup Sørbye
Lise C. Gaudernack
- BioMed Central
Neu im Fachgebiet Gynäkologie und Geburtshilfe
Meistgelesene Bücher aus dem Fachgebiet
e.Med Kampagnen-Visual, Mail Icon II